Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
American Journal of Cardiovascular Drugs
Published in: American Journal of Cardiovascular Drugs 1/2018

01-02-2018 | Research letter

Long-Term Follow-up of Patients with Coronary Slow Flow Phenomenon

Authors: Kenji Sadamatsu, Yasuaki Koga, Hideki Tashiro

Published in: American Journal of Cardiovascular Drugs | Issue 1/2018

Login to get access

Excerpt

The coronary slow flow phenomenon (CSFP) is an angiographic finding characterized by the delayed progression of contrast medium in an epicardial coronary artery without stenosis during routine coronary angiography. In daily practice at catheterization laboratories, coronary slow flow is not a rare finding; however, CSFP has received little attention, and its natural history is still unclear. We therefore conducted a long-term follow-up study of the patients with CSFP from our previous study [1]. …
Literature
1.
Sadamatsu K, Tashiro H, Yoshida K, Shikada T, Iwamoto K, Morishige K, Yoshidomi Y, Tokunou T, Tanaka H. Acute effects of isosorbide dinitrate and nicorandil on the coronary slow flow phenomenon. Am J Cardiovasc Drugs. 2010;10:203–8.CrossRefPubMed
2.
Fragasso G, Chierchia SL, Arioli F, Carandente O, Gerosa S, Carlino M, Palloshi A, Gianolli L, Calori G, Fazio F, Margonato A. Coronary slow-flow causing transient myocardial hypoperfusion in patients with cardiac syndrome X: long-term clinical and functional prognosis. Int J Cardiol. 2009;137:137–44.CrossRefPubMed
3.
Sadr-Ameli MA, Saedi S, Saedi T, Madani M, Esmaeili M, Ghardoost B. Coronary slow flow: benign or ominous? Anatol J Cardiol. 2015;15:531–5.CrossRefPubMed
4.
Sharif-Yakan A, Nienaber CA. Pharmacological management of cardiac syndrome Y: a focused review. Angiol Open Access. 2015;3:143.CrossRef
5.
Metadata
Title
Long-Term Follow-up of Patients with Coronary Slow Flow Phenomenon
Authors
Kenji Sadamatsu
Yasuaki Koga
Hideki Tashiro
Publication date
01-02-2018
Publisher
Springer International Publishing
Published in
American Journal of Cardiovascular Drugs / Issue 1/2018
Print ISSN: 1175-3277
Electronic ISSN: 1179-187X
DOI
https://doi.org/10.1007/s40256-017-0241-4

Other articles of this Issue 1/2018

American Journal of Cardiovascular Drugs 1/2018 Go to the issue

short communication

Provision of Lifestyle Counseling and the Prescribing of Pharmacotherapy for Hyperlipidemia Among US Ambulatory Patients: A National Assessment of Office-Based Physician Visits

Review Article

Pharmaceutical Interventions for Diabetes Prevention in Patients at Risk

Review Article

Macitentan in Pulmonary Arterial Hypertension: A Focus on Combination Therapy in the SERAPHIN Trial

Review Article

Benefit-Risk Assessment of Crataegus Extract WS 1442: An Evidence-Based Review

short communication

Ivabradine in Postural Orthostatic Tachycardia Syndrome: Preliminary Experience in Children

Original Research Article

Targeting the Prostacyclin Pathway with Selexipag in Patients with Pulmonary Arterial Hypertension Receiving Double Combination Therapy: Insights from the Randomized Controlled GRIPHON Study

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits